Review article · 2018

Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies

Katsuhiko Hagi, Tadashi Nosaka, Andrei Pikalov

Published 25 September 2018 · DOI 10.26226/morressier.5b68175cb56e9b005965c163

View at the publisherCite this paper

In brief

“Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies” is a 2018 review article by Katsuhiko Hagi and 2 co-authors. OpenAlex counts 0 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hagi, K., Nosaka, T., & Pikalov, A. (2018). Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies. https://doi.org/10.26226/morressier.5b68175cb56e9b005965c163

MLA 9

Hagi, Katsuhiko, et al. “Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies.” 2018. https://doi.org/10.26226/morressier.5b68175cb56e9b005965c163.

Chicago

Hagi, Katsuhiko, Tadashi Nosaka, and Andrei Pikalov. 2018. “Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies.” https://doi.org/10.26226/morressier.5b68175cb56e9b005965c163.

Harvard

Hagi, K., Nosaka, T. and Pikalov, A. (2018) ‘Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies’. doi:10.26226/morressier.5b68175cb56e9b005965c163.

IEEE

K. Hagi, T. Nosaka, and A. Pikalov, “Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies,” 2018, doi: 10.26226/morressier.5b68175cb56e9b005965c163.

BibTeX

@article{hagi2018safety,
  title     = {{Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies}},
  author    = {Hagi, Katsuhiko and Nosaka, Tadashi and Pikalov, Andrei},
  year      = {2018},
  doi       = {10.26226/morressier.5b68175cb56e9b005965c163},
  url       = {https://doi.org/10.26226/morressier.5b68175cb56e9b005965c163}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • lurasidone
  • schizophrenia
  • safety
  • tolerability
  • antipsychotic drugs
  • placebo comparison

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Hagi, K., Nosaka, T., & Pikalov, A. (2018). Safety and tolerability of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies. https://doi.org/10.26226/morressier.5b68175cb56e9b005965c163

How many times has this paper been cited?

0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Katsuhiko Hagi, Tadashi Nosaka, Andrei Pikalov.

What is the DOI of this paper?

10.26226/morressier.5b68175cb56e9b005965c163, permanently at https://doi.org/10.26226/morressier.5b68175cb56e9b005965c163. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.